To state the obvious: Drugs are increasingly complex and so are their patent lives.
More than 110 companies have graduated since bwtech@UMBC began offering incubation services in 1989.
Cell therapy is the delivery of living cells to treat, or potentially cure, a person’s disease. The transplantation of hematopoietic stem cells from a donor to a recipient to create bone marrow, for instance, is one well-established form of cell therapy.
Trajectory Next will provide formalized support and guidance to companies to help them execute a pilot, establish traction, and improve their ability to attract and attain customers.
TAI Diagnostics said earlier this week that it had closed a $10 million round of funding and forged a new partnership with United Therapeutics (NASDAQ: UTHR).
GlaxoSmithKline CEO Emma Walmsley made history in 2017, when she became the first woman to head up a major pharmaceutical company.
Once heralded as a centerpiece of DC’s tech scene, start-up incubator 1776 proved less revolutionary than its name.
AstraZeneca and MedImmune, its biologics research and development arm, announced that the European Commission (EC) has approved the companies’ respiratory biologic, benralizumab, as an add-on maintenance treatment for adults with severe eosinophilic asthma that is inadequately controlled despite high-dose inhaled corticosteroids, plus long-acting b-agonists.
In recent years, Lake Whillans has published extensively on the multifaceted interplay between the legal market and the life sciences industry, specifically identifying the most active and relevant law firms for life science companies.
The Jackson Laboratory has been awarded a $3.2 million grant from the National Institutes of Health to develop an epigenome modification technology for studying gene regulation in biological processes and disease states.